Vitae Pharmaceuticals focuses on creating and advancing innovative drugs for the treatment of diseases with unmet medical needs, including autoimmune disorders such as psoriasis and atopic dermatitis. Vitae Pharmaceuticals utilizes Contour® to discover and develop drugs for validated therapeutic targets against which the industry has traditionally struggled due to challenges related to potency, selectivity, pharmacokinetics, or patentability. This gives Vitae Pharmaceuticals’ scientists the ability to create first-in-class and best-in-class drugs for targets that are “difficult-to-drug.”
Vitae Pharmaceuticals Pipeline
We continue to invest in discovery activities utilizing CONTOUR®, our computational structure-based drug discovery platform, to design and optimize compounds, and which we use to discover molecules to targets with known biology, characterized as difficult to drug and with a high unmet medical need. During the second quarter of 2016, following the demonstration of animal proof-of-concept, we selected a new candidate which was generated from CONTOUR® for pre-clinical development for a currently undisclosed program. A patent has been filed covering the chemistry from the program.